Skip to main content
Top
Published in: BMC Nephrology 1/2016

Open Access 01-12-2016 | Study protocol

Protocol of a mixed method, randomized controlled study to assess the efficacy of a psychosocial intervention to reduce fatigue in patients with End-Stage Renal Disease (ESRD)

Authors: Wieke E. van der Borg, Karen Schipper, Tineke A. Abma

Published in: BMC Nephrology | Issue 1/2016

Login to get access

Abstract

Background

Patients with end-stage renal disease (ESRD) commonly suffer from severe fatigue, which strongly impacts their quality of life (QoL). Although fatigue is often attributed to disease- and treatment characteristics, research also shows that behavioural, psychological and social factors affect perceived fatigue in dialysis patients. Whereas studies on fatigue in other chronic patient groups suggest that psychological or psychosocial interventions are effective in reducing fatigue, such interventions are not yet available for ESRD patients on dialysis treatment. The objective of this study is to examine the efficacy of a psychosocial intervention for dialysis patients aimed at reducing fatigue (primary outcome) and improving QoL (secondary outcome). The intervention consists of counselling sessions led by a social worker. The implementation process and patients’ and social workers’ expectations and experiences with the intervention will also be evaluated.

Methods/Design

This study follows a mixed-methods design in which both quantitative and qualitative data will be collected. A multi-centre, randomised controlled trial (RCT) with repeated measures will be conducted to quantitatively assess the efficacy of the psychosocial intervention in reducing fatigue and improving QoL in ESRD patients. Additional secondary outcomes and medical parameters will be assessed. Outcomes will be compared to patients receiving usual care. A sample of 74 severely fatigued dialysis patients will be recruited from 10 dialysis centres. Patients will be randomly assigned to the intervention or control group. Outcomes will be assessed at baseline, post intervention/16 weeks, and at three and six-month follow-ups. A qualitative process evaluation will be conducted parallel to/following the effectiveness RCT. Interviews and focus groups will be conducted to gain insight into patients’ and social workers’ perspectives on outcomes and implementation procedures. Implementation fidelity will be assessed by audio-taped and written registrations. Participatory methods ensure the continuous input of experiential knowledge, improving the quality of study procedures and the applicability of outcomes.

Discussion

This is the first mixed method study (including an RCT and qualitative process evaluation) to examine the effect and implementation process of a psychosocial intervention on reducing fatigue and improving QoL in ESRD patients on dialysis treatment.

Trial registration

NTR5366, The Netherlands National Trial Register (NTR), registered August 26, 2015.
Appendix
Available only for authorised users
Literature
1.
go back to reference Anand S, Bitton A, Gaziano T. The gap between estimated incidence of end‐stage renal disease and use of therapy. Plos One. 2013;8(8):1–8.CrossRef Anand S, Bitton A, Gaziano T. The gap between estimated incidence of end‐stage renal disease and use of therapy. Plos One. 2013;8(8):1–8.CrossRef
2.
go back to reference Tong A, Ralph A, Chapman JR, Gill JS, Josephson MA, Hanon CS, et al. Public attitudes and beliefs about living kidney donation: focus group study. Transplantation. 2014;97(10):977–85.CrossRefPubMed Tong A, Ralph A, Chapman JR, Gill JS, Josephson MA, Hanon CS, et al. Public attitudes and beliefs about living kidney donation: focus group study. Transplantation. 2014;97(10):977–85.CrossRefPubMed
4.
go back to reference Landreneau K, Lee K, Landreneau MD. Quality of life in patients undergoing hemodialysis and renal transplantation-a meta-analytic review. Nephrol Nurs J. 2010;37(1):37–45.PubMed Landreneau K, Lee K, Landreneau MD. Quality of life in patients undergoing hemodialysis and renal transplantation-a meta-analytic review. Nephrol Nurs J. 2010;37(1):37–45.PubMed
6.
go back to reference Patel SR, Chadha P, Papalois V. Expanding the live kidney donor pool: ethical considerations regarding altruistic donors, paired and pooled programs. Exp Clin Transplant. 2011;9(3):181–6.PubMed Patel SR, Chadha P, Papalois V. Expanding the live kidney donor pool: ethical considerations regarding altruistic donors, paired and pooled programs. Exp Clin Transplant. 2011;9(3):181–6.PubMed
7.
go back to reference Gloor JM, DeGoey SR, Pineda AA, Moore SB, Prieto M, Nyberg SL, et al. Overcoming a positive crossmatch in living donor kidney transplantation. Am J Transplant. 2003;3(8):1017–23.CrossRefPubMed Gloor JM, DeGoey SR, Pineda AA, Moore SB, Prieto M, Nyberg SL, et al. Overcoming a positive crossmatch in living donor kidney transplantation. Am J Transplant. 2003;3(8):1017–23.CrossRefPubMed
8.
go back to reference Gebel HM, Bray RA, Nickerson P. Pre‐transplant assessment of donor‐reactive, HLA‐specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant. 2003;3(12):1488–500.CrossRefPubMed Gebel HM, Bray RA, Nickerson P. Pre‐transplant assessment of donor‐reactive, HLA‐specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant. 2003;3(12):1488–500.CrossRefPubMed
9.
go back to reference Nierstichting. Samen met anderen. Jaarverslag Nierstichting. 2014; Bussum. Nierstichting. Samen met anderen. Jaarverslag Nierstichting. 2014; Bussum.
10.
go back to reference Waterman AD, McSorley AMM, Peipert JD, Goalby CJ, Peace LJ, Lutz PA, et al. Explore transplant at home: a randomized control trial of an educational intervention to increase transplant knowledge for black and white socioeconomically disadvantaged dialysis patients. BMC Nephrol. 2015;16(1):150.CrossRefPubMedPubMedCentral Waterman AD, McSorley AMM, Peipert JD, Goalby CJ, Peace LJ, Lutz PA, et al. Explore transplant at home: a randomized control trial of an educational intervention to increase transplant knowledge for black and white socioeconomically disadvantaged dialysis patients. BMC Nephrol. 2015;16(1):150.CrossRefPubMedPubMedCentral
11.
go back to reference Abma T, Nierse C, Van de Griendt J, Schipper K, Van Zadelhoff E. Leren over lijf en leven. Een agenda voor sociaalwetenschappelijk onderzoek door nierpatiënten. Bussum: NSN; 2007. Abma T, Nierse C, Van de Griendt J, Schipper K, Van Zadelhoff E. Leren over lijf en leven. Een agenda voor sociaalwetenschappelijk onderzoek door nierpatiënten. Bussum: NSN; 2007.
12.
go back to reference Jhamb M, Weisbord SD, Steel JL, Unruh M. Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis. 2008;52(2):353–65.CrossRefPubMedPubMedCentral Jhamb M, Weisbord SD, Steel JL, Unruh M. Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis. 2008;52(2):353–65.CrossRefPubMedPubMedCentral
13.
go back to reference Bossola M, Vulpio C, Tazza L. Fatigue in chronic dialysis patients. Semin Dial. 2011;24(5):550–5.CrossRefPubMed Bossola M, Vulpio C, Tazza L. Fatigue in chronic dialysis patients. Semin Dial. 2011;24(5):550–5.CrossRefPubMed
14.
go back to reference Karakan S, Sezer S, Ozdemir FN. Factors related to fatigue and subgroups of fatigue in patients with end-stage renal disease. Clin Nephrol. 2011;76(5):358–64.CrossRefPubMed Karakan S, Sezer S, Ozdemir FN. Factors related to fatigue and subgroups of fatigue in patients with end-stage renal disease. Clin Nephrol. 2011;76(5):358–64.CrossRefPubMed
15.
16.
go back to reference Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82–99.CrossRefPubMed Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82–99.CrossRefPubMed
17.
go back to reference Lee BO, Lin CC, Chaboyer W, Chiang CL, Hung CC. The fatigue experience of haemodialysis patients in Taiwan. J Clin Nurs. 2007;16(2):407–13.CrossRefPubMed Lee BO, Lin CC, Chaboyer W, Chiang CL, Hung CC. The fatigue experience of haemodialysis patients in Taiwan. J Clin Nurs. 2007;16(2):407–13.CrossRefPubMed
18.
go back to reference Ream E, Richardson A. Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud. 1997;34(1):44–53.CrossRefPubMed Ream E, Richardson A. Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud. 1997;34(1):44–53.CrossRefPubMed
19.
go back to reference Aaronson LS, Teel CS, Cassmeyer V, Neuberger GB. Defining and measuring fatigue. J Nurs Scholarship. 1999;31(1):45.CrossRef Aaronson LS, Teel CS, Cassmeyer V, Neuberger GB. Defining and measuring fatigue. J Nurs Scholarship. 1999;31(1):45.CrossRef
20.
go back to reference Barany P, Pettersson E, Konarski-Svensson JK. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin. Nephrol Dial Transplant. 1993;8(5):426–32.PubMed Barany P, Pettersson E, Konarski-Svensson JK. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin. Nephrol Dial Transplant. 1993;8(5):426–32.PubMed
21.
go back to reference Portenoy RK, Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist. 1999;4(1):1–10.PubMed Portenoy RK, Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist. 1999;4(1):1–10.PubMed
22.
go back to reference Lappin TR, Maxwell AP, Johnston PG. EPO’s alter ego: erythropoietin has multiple actions. Stem Cells. 2002;20(6):485–92.CrossRefPubMed Lappin TR, Maxwell AP, Johnston PG. EPO’s alter ego: erythropoietin has multiple actions. Stem Cells. 2002;20(6):485–92.CrossRefPubMed
23.
go back to reference Jacobsen PB, Donovan KA, Vadaparampil ST, Small BJ. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol. 2007;26(6):660–7.CrossRefPubMedPubMedCentral Jacobsen PB, Donovan KA, Vadaparampil ST, Small BJ. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol. 2007;26(6):660–7.CrossRefPubMedPubMedCentral
24.
go back to reference Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull. 2008;134(5):700–41.CrossRefPubMed Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull. 2008;134(5):700–41.CrossRefPubMed
25.
go back to reference Gielissen MF, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol. 2006;24(30):4882–7.CrossRefPubMed Gielissen MF, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol. 2006;24(30):4882–7.CrossRefPubMed
26.
go back to reference Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008;26(28):4651–8.CrossRefPubMed Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008;26(28):4651–8.CrossRefPubMed
27.
go back to reference Dirksen SR, Epstein DR. Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs. 2008;61(6):664–75.CrossRefPubMed Dirksen SR, Epstein DR. Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs. 2008;61(6):664–75.CrossRefPubMed
28.
go back to reference Van der Lee ML, Garssen B. Mindfulness-based cognitive therapy reduces chronic cancer-related fatigue: a treatment study. Psychooncology. 2012;21(3):264–72.CrossRefPubMed Van der Lee ML, Garssen B. Mindfulness-based cognitive therapy reduces chronic cancer-related fatigue: a treatment study. Psychooncology. 2012;21(3):264–72.CrossRefPubMed
29.
go back to reference Ostelo RW, Van Tulder MW, Vlaeyen JW, Linton SJ, Morley SJ, Assendelft WJ. Behavioural treatment for chronic low-back pain. Cochrane Database Syst Rev. 2005;1:CD002014.PubMed Ostelo RW, Van Tulder MW, Vlaeyen JW, Linton SJ, Morley SJ, Assendelft WJ. Behavioural treatment for chronic low-back pain. Cochrane Database Syst Rev. 2005;1:CD002014.PubMed
30.
go back to reference Chambers D, Bagnall A, Hempel S, Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J R Soc Med. 2006;99:506–20.CrossRefPubMedPubMedCentral Chambers D, Bagnall A, Hempel S, Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J R Soc Med. 2006;99:506–20.CrossRefPubMedPubMedCentral
31.
go back to reference Prins JB, Bleijenberg G, Bazelmans E, Elving LD, De Boo TM, Severens JL, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet. 2001;357(9259):841–7.CrossRefPubMed Prins JB, Bleijenberg G, Bazelmans E, Elving LD, De Boo TM, Severens JL, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet. 2001;357(9259):841–7.CrossRefPubMed
32.
go back to reference Zedlitz A, Fasotti L. Omgaan met beperkte belastbaarheid. Behandelprotocol voor ambulante hersenletselpatiënten met (ernstige) vermoeidheid. Den Haag: Boom; 2010. Zedlitz A, Fasotti L. Omgaan met beperkte belastbaarheid. Behandelprotocol voor ambulante hersenletselpatiënten met (ernstige) vermoeidheid. Den Haag: Boom; 2010.
33.
go back to reference Voet NB, Bleijenberg G, Padberg GW, van Engelen BG, Geurts AC. Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial. BMC Neurol. 2010;10(1):56.CrossRefPubMedPubMedCentral Voet NB, Bleijenberg G, Padberg GW, van Engelen BG, Geurts AC. Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial. BMC Neurol. 2010;10(1):56.CrossRefPubMedPubMedCentral
34.
go back to reference Koopman FS, Beelen A, Gerrits KH, Bleijenberg G, Abma TA, de Visser M, et al. Exercise therapy and cognitive behavioural therapy to improve fatigue, daily activity performance and quality of life in postpoliomyelitis syndrome: the protocol of the FACTS-2-PPS trial. BMC Neurol. 2010;10(1):8.CrossRefPubMedPubMedCentral Koopman FS, Beelen A, Gerrits KH, Bleijenberg G, Abma TA, de Visser M, et al. Exercise therapy and cognitive behavioural therapy to improve fatigue, daily activity performance and quality of life in postpoliomyelitis syndrome: the protocol of the FACTS-2-PPS trial. BMC Neurol. 2010;10(1):8.CrossRefPubMedPubMedCentral
35.
go back to reference Dusenbury L, Brannigan R, Falco M, Hansen WB. A review of research on fidelity of implementation: implications for drug abuse prevention in school settings. Health Educ Res. 2003;18(2):237–56.CrossRefPubMed Dusenbury L, Brannigan R, Falco M, Hansen WB. A review of research on fidelity of implementation: implications for drug abuse prevention in school settings. Health Educ Res. 2003;18(2):237–56.CrossRefPubMed
36.
go back to reference Weck F, Bohn C, Ginzburg DM, Stangier U. Treatment integrity: implementation, assessment, evaluation, and correlations with outcome. Verhaltenstherapie. 2011;21(2):99–107.CrossRef Weck F, Bohn C, Ginzburg DM, Stangier U. Treatment integrity: implementation, assessment, evaluation, and correlations with outcome. Verhaltenstherapie. 2011;21(2):99–107.CrossRef
37.
go back to reference Muntinga ME, Hoogendijk EO, Van Leeuwen KM, Van Hout HP, Twisk JW, Van der Horst HE, et al. Implementing the chronic care model for frail older adults in the Netherlands: study protocol of ACT (frail older adults: care in transition). BMC Geriatr. 2012;12(1):19.CrossRefPubMedPubMedCentral Muntinga ME, Hoogendijk EO, Van Leeuwen KM, Van Hout HP, Twisk JW, Van der Horst HE, et al. Implementing the chronic care model for frail older adults in the Netherlands: study protocol of ACT (frail older adults: care in transition). BMC Geriatr. 2012;12(1):19.CrossRefPubMedPubMedCentral
38.
go back to reference De Wit M. Patient participation in rheumatology research. A four level responsive evaluation. Doctoral thesis: VU University Amsterdam; 2014. De Wit M. Patient participation in rheumatology research. A four level responsive evaluation. Doctoral thesis: VU University Amsterdam; 2014.
39.
go back to reference Hewlett S, Wit MD, Richards P, Quest E, Hughes R, Heiberg T, et al. Patients and professionals as research partners: challenges, practicalities, and benefits. Arthritis Care Res. 2006;55(4):676–80.CrossRef Hewlett S, Wit MD, Richards P, Quest E, Hughes R, Heiberg T, et al. Patients and professionals as research partners: challenges, practicalities, and benefits. Arthritis Care Res. 2006;55(4):676–80.CrossRef
40.
go back to reference Schipper K, Abma TA, Van Zadelhoff E, Van de Griendt J, Nierse C, Widdershoven GA. What does it mean to be a patient research partner? An ethnodrama. Qual Inq. 2010;16(6):501–10.CrossRef Schipper K, Abma TA, Van Zadelhoff E, Van de Griendt J, Nierse C, Widdershoven GA. What does it mean to be a patient research partner? An ethnodrama. Qual Inq. 2010;16(6):501–10.CrossRef
41.
go back to reference De Wit M, Abma T, Koelewijn-Van Loon M, Collins S, Kirwan J. Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences. BMJ Open. 2013;3(5):e002241.CrossRefPubMedPubMedCentral De Wit M, Abma T, Koelewijn-Van Loon M, Collins S, Kirwan J. Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences. BMJ Open. 2013;3(5):e002241.CrossRefPubMedPubMedCentral
42.
go back to reference Dudley L, Gamble C, Preston J, Buck D, Hanley B, EPIC Patient Advisory Group, et al. What difference does patient and public involvement make and what are its pathways to impact? Qualitative study of patients and researchers from a cohort of randomised clinical trials. PLoS One. 2015;10(6):e0128817.CrossRefPubMedPubMedCentral Dudley L, Gamble C, Preston J, Buck D, Hanley B, EPIC Patient Advisory Group, et al. What difference does patient and public involvement make and what are its pathways to impact? Qualitative study of patients and researchers from a cohort of randomised clinical trials. PLoS One. 2015;10(6):e0128817.CrossRefPubMedPubMedCentral
43.
go back to reference Vercoulen JHM, Alberts M, Bleijenberg G. De checklist individuele spankracht (CIS). Gedragstherapie. 1999;32:131–6. Vercoulen JHM, Alberts M, Bleijenberg G. De checklist individuele spankracht (CIS). Gedragstherapie. 1999;32:131–6.
44.
go back to reference Koopman FS, Brehm MA, Heerkens YF, Nollet F, Beelen, A. Measuring fatigue in polio survivors: content comparison and reliability of the fatigue severity scale and the checklist individual strength. J Rehabil Med. 2014;46(8):761–767. Koopman FS, Brehm MA, Heerkens YF, Nollet F, Beelen, A. Measuring fatigue in polio survivors: content comparison and reliability of the fatigue severity scale and the checklist individual strength. J Rehabil Med. 2014;46(8):761–767.
45.
go back to reference Knoop H, Blijenberg, G. Het chronisch vermoeidheidssyndroom. Behandelprotocol cognitieve gedragstherapie voor CVS. Bohn Stafleu van Loghum; 2010. Knoop H, Blijenberg, G. Het chronisch vermoeidheidssyndroom. Behandelprotocol cognitieve gedragstherapie voor CVS. Bohn Stafleu van Loghum; 2010.
46.
go back to reference Zedlitz AMEE,Fasotti L. Omgaan met beperkte belastbaarheid. Behandelprotocol voor ambulante hersenletselpatiënten met (ernstige) vermoeidheid. 2010. Zedlitz AMEE,Fasotti L. Omgaan met beperkte belastbaarheid. Behandelprotocol voor ambulante hersenletselpatiënten met (ernstige) vermoeidheid. 2010.
47.
go back to reference Bohlmeijer E, Hulsbergen M. Voluit leven. Mindfulness of de kunst van het aanvaarden, nu als praktisch hulpboek. Amsterdam: Boom; 2008. Bohlmeijer E, Hulsbergen M. Voluit leven. Mindfulness of de kunst van het aanvaarden, nu als praktisch hulpboek. Amsterdam: Boom; 2008.
48.
go back to reference Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOLTM) instrument. Qual Life Res. 1994;3(5):329–38.CrossRefPubMed Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOLTM) instrument. Qual Life Res. 1994;3(5):329–38.CrossRefPubMed
49.
go back to reference Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321(7262):694–6.CrossRefPubMedPubMedCentral Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321(7262):694–6.CrossRefPubMedPubMedCentral
51.
52.
go back to reference Oakley A, Strange V, Bonell C, Allen E, Stephenson J, RIPPLE Study Team. Health services research: process evaluation in randomised controlled trials of complex interventions. BMJ. 2006;332(7538):413.CrossRefPubMedPubMedCentral Oakley A, Strange V, Bonell C, Allen E, Stephenson J, RIPPLE Study Team. Health services research: process evaluation in randomised controlled trials of complex interventions. BMJ. 2006;332(7538):413.CrossRefPubMedPubMedCentral
53.
go back to reference Lincoln YS, Guba EG. Naturalistic inquiry (Vol. 75). Newbury Park, CA: Sage Publications; 1985. Lincoln YS, Guba EG. Naturalistic inquiry (Vol. 75). Newbury Park, CA: Sage Publications; 1985.
55.
go back to reference Green J, Thorogood N. Qualitative methods for health research. London: Sage; 2014. Green J, Thorogood N. Qualitative methods for health research. London: Sage; 2014.
56.
go back to reference Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef
57.
go back to reference Ridsdale L, Godfrey E, Chalder T, Seed P, King M, Wallace P, et al. Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. Br J Gen Pract. 2001;51:19–24.PubMedPubMedCentral Ridsdale L, Godfrey E, Chalder T, Seed P, King M, Wallace P, et al. Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. Br J Gen Pract. 2001;51:19–24.PubMedPubMedCentral
58.
go back to reference Van Sonderen E. Sociale steun lijst-interacties (SSL-i) en Sociale steun lijst-discrepanties (SSL-d). Groningen: Noordelijk Centrum voor Gezondheids-Vraagstukken; 1993. Van Sonderen E. Sociale steun lijst-interacties (SSL-i) en Sociale steun lijst-discrepanties (SSL-d). Groningen: Noordelijk Centrum voor Gezondheids-Vraagstukken; 1993.
59.
go back to reference Sanderman R, Ormel J. De utrechtse coping lijst (UCL): validiteit en betrouwbaarheid. Gedrag Gezond. 1992;20(1):32–7. Sanderman R, Ormel J. De utrechtse coping lijst (UCL): validiteit en betrouwbaarheid. Gedrag Gezond. 1992;20(1):32–7.
60.
go back to reference Evers AW, Kraaimaat FW, Van Lankveld W, Jongen PJ, Jacobs JW, Bijlsma JW. Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psych. 2001;69(6):1026.CrossRef Evers AW, Kraaimaat FW, Van Lankveld W, Jongen PJ, Jacobs JW, Bijlsma JW. Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psych. 2001;69(6):1026.CrossRef
61.
go back to reference Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D. The revised illness perception questionnaire (IPQ-R). Psychol Health. 2002;17(1):1–16.CrossRef Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D. The revised illness perception questionnaire (IPQ-R). Psychol Health. 2002;17(1):1–16.CrossRef
62.
go back to reference Garnefski N, Kraaij V. The cognitive emotion regulation questionnaire. Eur J Psychol Assess. 2007;23(3):141–9.CrossRef Garnefski N, Kraaij V. The cognitive emotion regulation questionnaire. Eur J Psychol Assess. 2007;23(3):141–9.CrossRef
63.
go back to reference Jacobsen PB, Andrykowski MA, Thors CL. Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol. 2004;72:355–61.CrossRefPubMedPubMedCentral Jacobsen PB, Andrykowski MA, Thors CL. Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol. 2004;72:355–61.CrossRefPubMedPubMedCentral
64.
go back to reference Jacobsen PB, Azzarello LM, Hann DM. Relation of catastrophizing to fatigue severity in women with breast cancer. Cancer Res Ther Control. 1999;8:155–64. Jacobsen PB, Azzarello LM, Hann DM. Relation of catastrophizing to fatigue severity in women with breast cancer. Cancer Res Ther Control. 1999;8:155–64.
65.
66.
go back to reference Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):1–7.CrossRef Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):1–7.CrossRef
Metadata
Title
Protocol of a mixed method, randomized controlled study to assess the efficacy of a psychosocial intervention to reduce fatigue in patients with End-Stage Renal Disease (ESRD)
Authors
Wieke E. van der Borg
Karen Schipper
Tineke A. Abma
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2016
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-016-0277-8

Other articles of this Issue 1/2016

BMC Nephrology 1/2016 Go to the issue